foxo4-dri human trial senolytic | FOXO4/p53 Interaction Blocker FOXO4-DRI UK | Senolytic Peptide
Description
& Sokolowski, C
Lojo N, Rasic Z, Zenko Sever A, Kolenc D, Vukusic D, Drmic D, et al
Yes, daily supplementation is safe when taken within recommended doses, supporting ongoing metabolic and immune functions
"International Locations"
